Aurora Cannabis (ACB) Total Debt (2018 - 2026)
Aurora Cannabis (ACB) posted quarterly Total Debt of $363144.4 for Q1 2026, down 99.25% year-on-year from $48.5 million in Q1 2025, and down 97.46% on a QoQ basis from $14.3 million in Q4 2025.
Aurora Cannabis (ACB) Total Debt (2018 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Total Debt for 9 consecutive years, with $363144.4 the latest figure, recorded in Q1 2026.
- Quarterly Total Debt fell 99.25% year-over-year to $363144.4 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $363144.4 (down 99.25% YoY) and the FY2026 annual result came in at $360357.6, down 99.28% from the prior year.
- Total Debt retreated to $363144.4 in Q1 2026 per ACB's latest filing, from $14.3 million in the prior quarter.
- Over the last five years, Total Debt for ACB reached as high as $164.1 million in Q2 2023 and fell as low as $273948.0 in Q1 2022.
- A 5-year average of $60.9 million and a median of $48.5 million in 2025 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2022 — Total Debt soared 18407.33% — and 2026, when it sank 99.25%.
- Year by year, Total Debt stood at $50.8 million in 2022, then soared by 119.69% to $111.6 million in 2023, then fell by 3.26% to $108.0 million in 2024, then sank by 86.76% to $14.3 million in 2025, then plunged by 97.46% to $363144.4 in 2026.
- According to Business Quant data, Total Debt over the past three periods registered $363144.4, $14.3 million, and $14.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 11.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.63 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 28.76 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.34 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.81 Bn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | 363,144.43 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 363,144.43 |
| Dec 31, 2025 | 14.29 Mn |
| Sep 30, 2025 | 14.26 Mn |
| Jun 30, 2025 | 35.52 Mn |
| Mar 31, 2025 | 48.51 Mn |
| Dec 31, 2024 | 107.97 Mn |
| Sep 30, 2024 | 100.97 Mn |
| Jun 30, 2024 | 102.10 Mn |
| Mar 31, 2024 | 42.49 Mn |
| Dec 31, 2023 | 111.61 Mn |
| Sep 30, 2023 | 137.31 Mn |
| Jun 30, 2023 | 164.09 Mn |
| Mar 31, 2023 | 42.62 Mn |
| Dec 31, 2022 | 50.80 Mn |
| Sep 30, 2022 | 50.78 Mn |
| Jun 30, 2022 | 11.37 Mn |
| Mar 31, 2022 | 273,947.96 |
| Dec 31, 2021 | 274,494.28 |
| Sep 30, 2021 | 389,260.56 |
| Jun 30, 2021 | 388,865.98 |